Michael Boeckh to Precursor Cell Lymphoblastic Leukemia-Lymphoma
This is a "connection" page, showing publications Michael Boeckh has written about Precursor Cell Lymphoblastic Leukemia-Lymphoma.
Connection Strength
0.116
-
Infectious complications of CD19-targeted chimeric antigen receptor-modified T-cell immunotherapy. Blood. 2018 01 04; 131(1):121-130.
Score: 0.116
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.